PCK2 and glioblastoma: The findings demonstrated that glioblastoma patients with high PCK2 expression showed substantial enrichment in various immune response pathways, including Toll-like, JAK, NOD-like, RIG, and Fc epsilon RI signaling (Fig. 3J).